news
Fixed-combination drug products for hypertension treatment
The FDA has released a set of guidance notes for sponsors looking to combine approved hypertension drugs for more effective treatments...
List view / Grid view
hypertension
news
Inhaled blood pressure drug shows promise in treating anxiety and pain
The inhaled version of a high blood pressure drug may treat some types of anxiety and pain, reveals new research from the Centre for Addiction and Mental Health...
news
Better outcomes for patients using single-pill combination for hypertension
Findings may represent simple and potentially low-cost intervention...
news
FGF inhibitors may provide a new way to treat high blood pressure
Drugs designed to halt cancer growth may offer a new way to control high blood pressure...
news
AstraZeneca enters agreement with Recordati for Seloken in Europe
24 May 2017 | By Niamh Marriott, Junior Editor
AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK treatments in Europe...
news
FDA grants Kitov waiver for new drug application filing fee
6 April 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration (FDA) has granted Kitov Pharmaceuticals a waiver related to the $2,038,100 new drug application filing fee for KIT-302...
news
Major global study reveals new hypertension and blood pressure genes
13 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The discoveries include DNA changes in three rare genes that have much larger effects on blood pressure in the population than previously seen, providing new insights into the physiology of hypertension and suggesting new targets for treatment...
news
FDA approves Allergan’s hypertension drug Byvalson
7 June 2016 | By Victoria White, Digital Content Producer
Byvalson is the first and only fixed-dose combination (FDC) of a beta blocker (BB) and angiotensin II receptor blocker (ARB) available in the US...
